Biotech Startups

Scilex Holding Company (Nasdaq: SCLX) acquires, develops, and commercializes non-opioid pain management products for treating acute and chronic pain. It operates in the pharmaceutical industry, offering topical delivery systems and oral analgesic formulations.

1 investor

SciLifeLab is a Swedish national research infrastructure organization that provides advanced technologies, expertise, and support services to life science researchers across Swedish universities. The organization operates ten national platforms offering various technologies and services through specialized units.

1 investor

1 investor

ScionX develops xRNA, an engineered RNA platform that uses site-specific chemical modifications and expanded non-natural building blocks to extend protein expression from days to months and deliver multiple coordinated payloads against several disease drivers. It applies a deep-learning design engine and combinatorial chemical synthesis to build long-acting RNA therapeutics, initially focused on cardiometabolic and other chronic diseases.

1 investor

Sciphage develops phage-based products and operates a production facility in Colombia, positioning itself as a pioneer in bacteriophage applications within Latin America's industrial sector.

1 investor

SciRouter develops science-led daily supplements for humans, dogs and cats, with formulas that list active ingredients and doses tied to published research. It targets consumers interested in longevity and healthy aging for themselves and their pets.

1 investor

SciSafe provides biopharmaceutical storage, sample management, and cold chain logistics services for pharmaceutical companies, research institutes, and biotech firms across regulated temperature-controlled facilities. The company operates internationally with locations in New Jersey, Massachusetts, and the Netherlands, maintaining FDA, EU GDP, ISO, and CAP certifications.

1 investor

Scispot builds LabOS, a lab operating system that connects instruments, apps, and data sources into one governed data layer with automation, compliance tracking, and AI agents. It serves laboratories—including CROs and biology labs—to automate workflows, reporting, and audit-readiness.

1 investor

Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics. The platform serves life sciences companies and other science-based industries operating in regulated environments.

1 investor

Scitherm uses enzymatic synthesis to create novel structural variants with thermogenic activity, validated through channel affinity, in-vitro lipolysis, and in-vivo fat mass reduction studies. The company develops science-based thermal solutions aimed at metabolic health.

1 investor

Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally. It advances internal R&D programs and pursues out-licensing partnerships to bring treatments to market.

1 investor

Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.

1 investor

ScopeSys develops single-molecule imaging technology, called Convex Lens-induced Confinement (CLiC), that enables high-throughput measurements with single-molecule resolution for genomic-medicine drug development. Its platform helps developers of RNA, DNA, and nanoparticle-delivered drugs analyze single-molecule interactions to optimize therapeutic sequences and mRNA lipid nanoparticle formulations.

1 investor

Score Pharma is a biotech company developing biosuperior antibody therapeutics aimed at cancer treatment.

1 investor

ScotBio develops products through biotechnology, bringing together scientists and business staff to create offerings aimed at consumers and commercial partners. The page describes the team but provides limited detail on the specific products.

1 investor

scPharmaceuticals was a commercial-stage biopharmaceutical company that developed FUROSCIX, an FDA-approved subcutaneous formulation of the diuretic furosemide for treating fluid overload in heart failure and kidney disease patients.

1 investor

ScreenIn3D develops a lab-on-a-chip and 3D cell culture screening platform to accelerate drug discovery for pharmaceutical clients. The company is a University of Strathclyde spin-off based in Glasgow, UK.

1 investor

Scripps Research is a nonprofit research institute that combines fundamental science with drug discovery to advance treatments for human health. It focuses on translating scientific research into medicines for patients.

1 investor

SD BIOSENSOR is a company involved in sustainable management and economic value creation, publishing an annual sustainability management report. The page content available describes only its sustainability reporting rather than its core products or services.

1 investor

Sea & Believe cultivates native Irish Palmaria palmata seaweed using vertical and regenerative farming to produce MAA-rich extracts for cosmetics (natural UV protection, brightening, anti-aging) and as a functional feed additive for aquaculture, notably shrimp. The company, which also offers dried seaweed as a culinary product, is based in Connemara, Ireland.

1 investor

Sea4Us develops marine-derived treatments and compounds targeting unmet clinical needs. The company conducts research and development on marine organisms and their bioactive properties for pharmaceutical and healthcare applications.

1 investor

SEADLING is a seaweed biotech company that develops nutrient-rich, fermented seaweed-based ingredients for food, agriculture, and animal applications through large-scale farming and advanced biotechnology. Founded in 2018 and based in Malaysian Borneo, the company combines scientific innovation with sustainability practices and collaboration with local coastal communities.

1 investor

Sebela Pharmaceuticals markets and distributes pharmaceutical products to healthcare providers throughout the United States, with select products also sold internationally through marketing partners.

1 investor

Sebia is an in vitro diagnostics company that develops equipment and reagents based on capillary electrophoresis technology for screening and monitoring diseases such as multiple myeloma, diabetes, hemoglobinopathies, and autoimmune and infectious diseases. It serves clinical diagnostic laboratories globally, focusing on chronic and metabolic conditions.

1 investor